Cargando…
Orbital and chorioretinal manifestations of Erdheim-Chester disease treated with vemurafenib
PURPOSE: We report a patient with severe multi-organ dysfunction of unknown origin who presented with bilateral orbital and chorioretinal manifestations that led to the diagnosis of Erdheim-Chester Disease (ECD). OBSERVATIONS: ECD is a rare, histiocytic, proliferative disorder characterized by multi...
Autores principales: | Huang, Laura C., Topping, Katie L., Gratzinger, Dita, Brown, Ryanne A., Martin, Beth A., Silva, Ruwan A., Kossler, Andrea L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076364/ https://www.ncbi.nlm.nih.gov/pubmed/30094395 http://dx.doi.org/10.1016/j.ajoc.2018.07.005 |
Ejemplares similares
-
Multimodal Chorioretinal Imaging in Erdheim-Chester Disease
por: Sacconi, Riccardo, et al.
Publicado: (2020) -
Vemurafenib for BRAF V600‐mutant Erdheim–Chester disease presenting with bilateral orbital involvement
por: Wang, Xiaomeng, et al.
Publicado: (2023) -
Vemurafenib in the Treatment of Erdheim Chester Disease: A Systematic Review
por: Aziz, Syed N, et al.
Publicado: (2022) -
An effective treatment in Erdheim Chester disease: vemurafenib: a case report
por: Bozan, Ersin, et al.
Publicado: (2023) -
Neurological manifestations of Erdheim–Chester Disease
por: Boyd, Louisa C., et al.
Publicado: (2020)